BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27906722)

  • 1. Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy.
    Bittner N; Merrick G; Taira A; Bennett A; Schattel A; Butler W; Galbreath R; Adamovich E
    Am J Clin Oncol; 2018 Aug; 41(8):723-729. PubMed ID: 27906722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.
    Lee CU; Sung SH; Jang CT; Kang M; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    Urol Int; 2019; 103(3):262-269. PubMed ID: 31269509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very-Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance.
    Merrick GS; Delatore A; Butler WM; Bennett A; Fiano R; Anderson R; Adamovich E
    Am J Clin Oncol; 2017 Feb; 40(1):53-59. PubMed ID: 25068472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer.
    Ahallal Y; Sanchez-Salas R; Sivaraman A; Barret E; Secin FP; Validire P; Rozet F; Galiano M; Cathelineau X
    Actas Urol Esp; 2016 Dec; 40(10):615-620. PubMed ID: 27527686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferation.
    Merrick GS; Galbreath RW; Bennett A; Butler WM; Amamovich E
    World J Urol; 2017 Jul; 35(7):1009-1013. PubMed ID: 27900453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
    Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
    J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Comparison of Selective Multiparametric Magnetic Resonance Imaging Fusion-Targeted and Systematic Transrectal Ultrasound-Guided Biopsies for Detecting Prostate Cancer in Men Undergoing Repeated Biopsies.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
    Urol Int; 2017; 99(4):384-391. PubMed ID: 28651247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillance.
    Taira AV; Merrick GS; Bennett A; Andreini H; Taubenslag W; Galbreath RW; Butler WM; Bittner N; Adamovich E
    Am J Clin Oncol; 2013 Apr; 36(2):116-20. PubMed ID: 22307210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate.
    Bittner N; Merrick GS; Stewart R; Andreini H; Taubenslag W; Curtis R; Butler WM; Wallner KE
    Urol Oncol; 2011; 29(4):398-404. PubMed ID: 19945303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting.
    Taira AV; Merrick GS; Galbreath RW; Andreini H; Taubenslag W; Curtis R; Butler WM; Adamovich E; Wallner KE
    Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):71-7. PubMed ID: 19786982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience.
    Ong WL; Weerakoon M; Huang S; Paul E; Lawrentschuk N; Frydenberg M; Moon D; Murphy D; Grummet J
    BJU Int; 2015 Oct; 116(4):568-76. PubMed ID: 25560926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Single Center Evaluation of the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging against Transperineal Prostate Mapping Biopsy: An Analysis of Men with Benign Histology and Insignificant Cancer following Transrectal Ultrasound Biopsy.
    Pal RP; Ahmad R; Trecartan S; Voss J; Ahmed S; Bazo A; Lloyd J; Walton TJ
    J Urol; 2018 Aug; 200(2):302-308. PubMed ID: 29477717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
    Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
    Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
    Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
    Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
    Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
    Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pelvic MRI combined with TRUS-guided transperineal template mapping biopsy for the diagnosis of prostate cancer].
    Li Q; Xie JJ; Cao WZ; Deng JP; Liu C; Cui Y; Shao Q; Shen H
    Zhonghua Nan Ke Xue; 2019 May; 25(5):408-413. PubMed ID: 32216225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies.
    Sheikh N; Wei C; Szewczyk-Bieda M; Campbell A; Memon S; Lang S; Nabi G
    World J Urol; 2017 Feb; 35(2):213-220. PubMed ID: 27236302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies.
    Nafie S; Pal RP; Dormer JP; Khan MA
    World J Urol; 2014 Aug; 32(4):971-5. PubMed ID: 24337167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological Concordance between Prostate Biopsies and Radical Prostatectomy Using Transperineal Sector Mapping Biopsies: Validation and Comparison with Transrectal Biopsies.
    Marra G; Eldred-Evans D; Challacombe B; Van Hemelrijck M; Polson A; Pomplun S; Foster CS; Brown C; Cahill D; Gontero P; Popert R; Muir G
    Urol Int; 2017; 99(2):168-176. PubMed ID: 28768264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.